Improving Recombinant Zoster Vaccination Rates in Patients Receiving Biologic Therapy

Authors

Kathlyn Camargo, HCA HealthcareFollow
Taylor Kann, HCA HealthcareFollow
Marilyn Mosquera, HCA HealthcareFollow
Ravi Shahu, HCA HealthcareFollow
Ariail Schmitz, HCA HealthcareFollow
Kathleen McCabe, HCA HealthcareFollow
Ashwini Komarla, HCA HealthcareFollow

Files

Division

North Florida

Hospital

Osceola Regional Medical Center

Specialty

Rheumatology

Document Type

Presentation

Publication Date

2023

Keywords

recombinant zoster, biologic, vaccination, Shingrix, shingles, varicella-zoster virus

Disciplines

Medicine and Health Sciences | Rheumatology | Virus Diseases

Original Publisher

UCF/VA QI & Patient Safety Forum

Recommended Citation

Camargo, Kathlyn; Kann, Taylor; Mosquera, Marilyn; Shahu, Ravi; Schmitz, Ariail; McCabe, Kathleen; and Komarla, Ashwini, "Improving Recombinant Zoster Vaccination Rates in Patients Receiving Biologic Therapy" (2023). North Florida Division Research Day 2023. 17.
https://scholarlycommons.hcahealthcare.com/northflorida2023/17